Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Replimune (REPL) Payables (2018 - 2025)

Replimune has reported Payables over the past 8 years, most recently at $5.6 million for Q4 2025.

  • Quarterly results put Payables at $5.6 million for Q4 2025, down 21.44% from a year ago — trailing twelve months through Dec 2025 was $5.6 million (down 21.44% YoY), and the annual figure for FY2025 was $12.5 million, up 383.44%.
  • Payables reached $5.6 million in Q4 2025 per REPL's latest filing, down from $6.4 million in the prior quarter.
  • Across five years, Payables topped out at $15.5 million in Q2 2025 and bottomed at $864000.0 in Q2 2024.
  • Median Payables over the past 5 years was $4.2 million (2022), compared with a mean of $5.3 million.
  • The largest annual shift saw Payables plummeted 82.31% in 2024 before it skyrocketed 1692.01% in 2025.
  • Over 5 years, Payables stood at $3.9 million in 2021, then fell by 6.99% to $3.6 million in 2022, then rose by 6.99% to $3.9 million in 2023, then surged by 84.17% to $7.2 million in 2024, then decreased by 21.44% to $5.6 million in 2025.
  • Business Quant data shows Payables for REPL at $5.6 million in Q4 2025, $6.4 million in Q3 2025, and $15.5 million in Q2 2025.